The Choice of Outcome Parameters and Need for Distinct Assessment Tools with Regard to the Different Disease Stages in Alzheimer’s Disease (Video)

Presenter – Martha Brumfield, PhD, President and CEO, Critical Path Institute

Conference – European Medicines Agency workshop on the clinical investigation of medicines for the treatment of Alzheimer’s disease; November 24-25, 2014; London, UK

 

Video courtesy of the European Medicines Agency.

 

share
Facebook